Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes

dc.contributor.authorBeam, Craig A.
dc.contributor.authorBeli, Eleni
dc.contributor.authorWasserfall, Clive H.
dc.contributor.authorWoerner, Stephanie E.
dc.contributor.authorLegge, Megan T.
dc.contributor.authorEvans-Molina, Carmella
dc.contributor.authorMcGrail, Kieran M.
dc.contributor.authorSilk, Ryan
dc.contributor.authorGrant, Maria B.
dc.contributor.authorAtkinson, Mark A.
dc.contributor.authorDiMeglio, Linda A.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2023-02-10T18:56:42Z
dc.date.available2023-02-10T18:56:42Z
dc.date.issued2021-08
dc.description.abstractAims/hypothesis: The circadian clock influences both diabetes and immunity. Our goal in this study was to characterise more thoroughly the circadian patterns of immune cell populations and cytokines that are particularly relevant to the immune pathology of type 1 diabetes and thus fill in a current gap in our understanding of this disease. Methods: Ten individuals with established type 1 diabetes (mean disease duration 11 years, age 18-40 years, six female) participated in a circadian sampling protocol, each providing six blood samples over a 24 h period. Results: Daily ranges of population frequencies were sometimes large and possibly clinically significant. Several immune populations, such as dendritic cells, CD4 and CD8 T cells and their effector memory subpopulations, CD4 regulatory T cells, B cells and cytokine IL-6, exhibited statistically significant circadian rhythmicity. In a comparison with historical healthy control individuals, but using shipped samples, we observed that participants with type 1 diabetes had statistically significant phase shifts occurring in the time of peak occurrence of B cells (+4.8 h), CD4 and CD8 T cells (~ +5 h) and their naive and effector memory subsets (~ +3.3 to +4.5 h), and regulatory T cells (+4.1 h). An independent streptozotocin murine experiment confirmed the phase shifting of CD8 T cells and suggests that circadian dysrhythmia in type 1 diabetes might be an effect and not a cause of the disease. Conclusions/interpretation: Future efforts investigating this newly described aspect of type 1 diabetes in human participants are warranted. Peripheral immune populations should be measured near the same time of day in order to reduce circadian-related variation.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationBeam CA, Beli E, Wasserfall CH, et al. Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes. Diabetologia. 2021;64(8):1822-1833. doi:10.1007/s00125-021-05468-6en_US
dc.identifier.urihttps://hdl.handle.net/1805/31218
dc.language.isoen_USen_US
dc.publisherSpringeren_US
dc.relation.isversionof10.1007/s00125-021-05468-6en_US
dc.relation.journalDiabetologiaen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectCircadian rhythmsen_US
dc.subjectClinicalen_US
dc.subjectImmune cellsen_US
dc.subjectType 1 diabetesen_US
dc.titlePeripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
125_2021_Article_5468.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: